Article
EU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts reported
Rating:
0.0
Views:
35
Likes:
1
Library:
1
The European Medicines Agency (EMA) is investigating Novo Nordisk's diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland's health regulator flagged three cases of patients thinking about suicide or self-harm.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value